Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) Currently -259.09% Below Its 52-Week High, But There May Be A Surprise Downside
In last trading session, Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) saw 0.54 million shares changing hands with its beta currently measuring 0.33. Company’s recent per share